11 September 2023It was Geoff’s young grandson who first noticed that something wasn’t quite right with his grandfather. After his family called triple zero (000), the Mobile Stroke Unit (MSU) was dispatched. (Photo: Herald Sun)
04 September 2023
The RMH neurologist and The Florey Institute researcher Dr Thanuja Dharmadasa has received funding for three grants in a record investment from FightMND.
28 July 2023Researchers from the Royal Melbourne Hospital (RMH) have conducted a ground-breaking study comparing different treatment options for highly active relapsing-remitting multiple sclerosis (MS) patients who have shown limited response to conventional therapies.
16 March 2023
Greg suffered a major stroke in late 2022, something he understatedly describes as an ‘interesting experience’.
13 February 2023A recent study has shown that endovascular thrombectomy, a minimally invasive procedure that removes blood clots, can improve the outcomes of patients with large ischaemic strokes.
20 July 2022
An international, randomised controlled ischaemic stroke trial DIRECT-SAFE suggests acute stroke treatment should be adapted based on ethnicity and race.
03 June 2022A large international study has found that the severity of multiple sclerosis (MS) can vary depending on latitude, with those living furthest from the equator worse affected by the disease.
09 May 2022
A randomised controlled drug trial suggests clot-busting drug Tenecteplase provides better outcomes for stroke patients compared to the current standard of care alteplase.
We provide a media service from 6am to 10pm each day. Journalists are welcome to contact our media advisor on-call via the RMH Switchboard on (03) 9342 7000.
During business hours, journalists can email firstname.lastname@example.org. We do not respond to emails outside business hours.